Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: To investigate, through immunohistochemistry, the interaction between epithelial-mesenchymal transition (EMT) and the immune checkpoint proteins PD-1 and PD-L1 in oral tongue squamous cell carcinoma (OTSCC).

Design: The EMT status was determined based on the immunostaining of E-cadherin and N-cadherin proteins. EMT status and the immunoexpression of PD-L1 and PD-1 were analyzed semiquantitatively in 61 cases of OTSCC, and the cases were categorized into low and high expression groups for association with clinicopathological variables and overall survival (OS) and disease-free survival (DFS) rates.

Results: A predominance of cases with positive EMT status was identified (75.4 %), with a statistically significant association between histological grade of malignancy and the occurrence of EMT (p = 0.003). Regarding the clinical parameters analyzed, a statistically significant difference was observed between OTSCC cases with larger sizes and higher levels of PD-L1 expression (p = 0.048). Additionally, the immunoexpressions of the PD-1 and PD-L1 proteins were higher in cases with positive EMT status (p = 0.003 and p = 0.001, respectively), as well as a moderate, positive, and statistically significant correlation between the immunoexpression scores of PD-1 and PD-L1 proteins (r = 0.571; p < 0.001).

Conclusion: The results of the present study suggest the potential involvement of EMT in the modulation of an immunosuppressive microenvironment in OTSCC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.archoralbio.2025.106304DOI Listing

Publication Analysis

Top Keywords

emt status
16
pd-1 pd-l1
12
interaction epithelial-mesenchymal
8
epithelial-mesenchymal transition
8
otscc cases
8
cases positive
8
positive emt
8
pd-l1 proteins
8
emt
6
pd-l1
5

Similar Publications

Over the past few decades, cancer research has increasingly focused on tumor microenvironment (TME). The TME contains diverse cellular components and secreted factors, including leukocytes, endothelial cells, cancer-associated fibroblasts, and other non-cancerous cells and extracellular matrix proteins. The interactions between tumor cells and microenvironment elements are complex and unpredictable.

View Article and Find Full Text PDF

The molecular circadian clock is known to be disrupted in lung adenocarcinoma, and its disruption is pro-tumorigenic in mouse models of this disease. However, the determinants of disruption of the molecular clock in human cancer are not clear. We hypothesized that derangement in expression of specific circadian clock genes or elevated MYC expression could correlate with circadian disruption in human tumors, and used Clock Correlation Distance (CCD) to compare clock order and strength in tumors based on the expression of these genes.

View Article and Find Full Text PDF

Glioma is one of the most aggressive and lethal brain tumors, with poor prognosis and limited treatment options. This study examined the function of CLEC18B in glioma development and its viability as a predictive biomarker. Pan-cancer research demonstrated that CLEC18B is dysregulated in several tumor types, with elevated expression associated with reduced overall survival (OS) and disease-specific survival (DSS) in patients with different malignancies, including glioma.

View Article and Find Full Text PDF

IDH-mutant gliomas show prognostic heterogeneity despite favorable overall outcomes, necessitating refined molecular classification. While the extracellular matrix (ECM) critically regulates tumor progression, immunity, and EMT, its prognostic significance in IDH-mutant gliomas remains largely unexplored. Here, we employed unsupervised clustering of ECM-related genes across multiple glioma cohorts, identifying two distinct molecular subtypes: ECM1 and ECM2.

View Article and Find Full Text PDF

Background: Serum carcinoembryonic antigen (CEA) has potential prognostic and monitoring significance in lung adenocarcinoma (LUAD) patients undergoing different treatments, such as epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) and chemotherapy. The changes in CEA expression during relapses, influenced by resistance mechanisms involving cytokines and epigenetic factors, may impact its utility in disease prognosis, monitoring, and management.

Methods: This retrospective study analyzed advanced LUAD patients treated between 2011 and 2018, including 182 patients receiving EGFR-TKIs and 102 undergoing chemotherapies.

View Article and Find Full Text PDF